S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial
BATS:ARKG

ARK Genomic Revolution ETF (ARKG) Price, Holdings, & News

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)
Free ARKG Stock Alerts
$23.31
-0.24 (-1.02%)
(As of 04/19/2024 ET)
Compare
Today's Range
$22.93
▼
$23.80
50-Day Range
$23.55
▼
$32.97
52-Week Range
N/A
Volume
3.52 million shs
Average Volume
N/A
Market Capitalization
$1.29 billion
Assets Under Management
$1.30 billion
Dividend Yield
N/A
Net Expense Ratio
0.75%
Stock AnalysisChartHeadlinesHoldingsOwnershipRatings
ARKG stock logo

About ARK Genomic Revolution ETF (BATS:ARKG)

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.

ARKG Stock Price History

ARKG ETF News Headlines

April 19, 2024 | americanbankingnews.com
ARK Genomic Revolution ETF Sees Unusually High Options Volume (BATS:ARKG)
April 17, 2024 | msn.com
Standard BioTools (LAB) Price Target Decreased by 10.42% to 3.65
April 19, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
April 14, 2024 | nasdaq.com
ARK Genomic Revolution (ARKG) Enters Oversold Territory
March 26, 2024 | markets.businessinsider.com
Cathie Wood's Ark Takes Profits In Rallying Crypto Stocks, Trims Nvidia And This COVID-19 Play Further
March 25, 2024 | fool.com
Cathie Wood Is Selling This High-Yield Dividend Stock. Should You?
March 19, 2024 | investorplace.com
3 Biotech ETFs Overdue for a Bounce
February 23, 2024 | markets.businessinsider.com
Here's How Much Cathie Wood, Ark Invest Flagship Fund Missed By Selling Nvidia Early
April 19, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
February 23, 2024 | wsj.com
ARK Genomic Revolution ETF
See More Headlines
Receive ARKG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ARK Genomic Revolution ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
ARK
Fund Name
ARK Genomic Revolution ETF
Tax Classification
Regulated Investment Company
Stock Exchange
BATS
Current Symbol
BATS:ARKG
Inception Date
10/31/2014
Fund Manager
Catherine Wood
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
N/A
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
42

Fund Statistics

Assets Under Management
$1.30 billion
Average Daily Volume
$2.13 million
Discount/Premium
-0.01%

Administrator, Advisor and Custodian

Administrator
The Bank of NewYork Mellon Corporation
Advisor
ARK Investment Management LLC
Custodian
The Bank of NewYork Mellon Corporation
Distributor
Foreside Fund Services, LLC
Transfer Agent
The Bank of NewYork Mellon Corporation
Trustee
N/A
Lead Market Maker
Jane Street

Options

Optionable
Optionable
Options Volume
15,865
Put Options
12,469
Call Options
3,396

Miscellaneous

Outstanding Shares
55,200,000
Beta
1.94
Creation Unit
50,000
Creation Fee
$500.00
Beginners Guide To Retirement Stocks Cover
Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Ad Gold Safe Exchange
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
Click here now to download the free Precious Metals Buying Guide!

ARK Genomic Revolution ETF Expenses

TypeARKGTheme ETFsEquity ETFsBATS ETFsAll ETFs
Management Fee0.75%0.57%0.54%0.56%0.51%
Other Expenses0.00%0.72%0.54%0.51%0.58%
Total Expense0.75%0.72%0.70%0.68%0.70%
Fee Waiver0.00%-0.76%-0.55%-0.34%-0.57%
Net Expense0.75%0.59%0.60%0.63%0.58%

ARK Genomic Revolution ETF (ARKG) Holdings & Exposure

Top 10 ARKG Holdings

ARKG Sector Exposure

ARKG Industry Exposure

Full Holdings Details

ARKG ETF - Frequently Asked Questions

How have ARKG shares performed in 2024?

ARK Genomic Revolution ETF's stock was trading at $32.81 on January 1st, 2024. Since then, ARKG shares have decreased by 28.2% and is now trading at $23.55.
View the best growth stocks for 2024 here.

What does ARKG invest in?

ARK Genomic Revolution ETF is a equity fund issued by ARK. ARKG focuses on theme investments. The fund's investments total to approximately $1.30 billion assets under management.

What stocks does ARK Genomic Revolution ETF hold?

ARKG invests in 43 holdings. Some of the stocks in their portfolio include CRISPR Therapeutics (CRSP), Twist Bioscience (TWST), Exact Sciences (EXAS), Recursion Pharmaceuticals (RXRX), Schrödinger (SDGR), Intellia Therapeutics (NTLA), Ionis Pharmaceuticals (IONS), 10x Genomics (TXG), Beam Therapeutics (BEAM) and Arcturus Therapeutics (ARCT).

What is the management fee for ARK Genomic Revolution ETF?

ARK Genomic Revolution ETF's management fee is 0.75% and has no other recorded expenses or fee waivers. The net expense ratio for ARKG is 0.75%.

Who are ARK Genomic Revolution ETF's major shareholders?

ARK Genomic Revolution ETF's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include IMC Chicago LLC (0.00%), Purus Wealth Management LLC (0.13%), Brookstone Capital Management (0.12%), Wealth Enhancement Advisory Services LLC (0.07%), Summit Investment Advisory Services LLC (0.03%) and Brown Miller Wealth Management LLC (0.03%).

How do I buy shares of ARK Genomic Revolution ETF?

Shares of ARKG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (BATS:ARKG) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
SHOCKING Crypto Leak…
Crypto 101 Media
The #1 Crypto for 2024
InvestorPlace
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started
Banyan Hill Publishing
How Biden has already won 2024
Porter & Company